Decreased TrxR1 activity without changes in TrxR1 levels has been implicated in age-related macular degeneration and glaucoma resulting from overexpression of amyloid β peptides (25), indicating that post-translational modifications control TrxR1 activity. The gene discussed is TXNRD1; the disease is glaucoma.